董事介绍

注:董事持股数取自最新公司公告

姓名 性别 职位 年龄 薪酬 持股数(万股) 截止日期
Eitan Machover Director 56 11.48万美元 未持股 2018-07-31
Eugene Saragnese Chairman of the Board and Chief Executive Officer 61 887.90万美元 未持股 2018-07-31
Sim Mann Director 41 未披露 未持股 2018-07-31
Barak Avraham Salomon Director 48 未披露 未持股 2018-07-31

高管介绍

注:高管持股数取自最新公司公告

姓名 性别 职位 年龄 薪酬 持股数(万股) 截止日期
Eugene Saragnese Chairman of the Board and Chief Executive Officer 61 887.90万美元 未持股 2018-07-31
Robert Jonathan Mehler Chief Operating Officer 48 205.04万美元 未持股 2018-07-31
Michael Rosenberg Chief Financial Officer 46 205.23万美元 未持股 2018-07-31
Christopher Alan Schnee Senior Vice President, Commercial Operations 47 未披露 未持股 2018-07-31

董事简历

中英对照 |  中文 |  英文
Eitan Machover

Eitan Machover自2014年12月起担任公司董事。Machover先生自2011年8月起担任EM Advisory Services的负责人和所有者。Machover自2006年1月起担任Ziegler Meditech Equity Partners,L.P.(一家专注于医疗设备领域的基金)合伙人。他担任众多上市和私人公司董事会的基金代表,包括:Brenmiller Energy,Ltd.。TASE:BNRG,自2017年7月起;WCG Properties,Ltd.(TASE:WCG.B2),自2017年6月起;Electra Real Estate(TASE:ELCRE),自2014年10月起;Related Commercial Portfolio,Ltd.(TASE:RLCM.B1),自2015年7月起;Medigus,Ltd.(TASE:MDGS,NASDAQ:MDGS),自2016年9月起;以及Epsilon Underwriting,Ltd.,自2015年12月起。Machover从2013年1月到2014年4月担任Enhanced Surface Dynamics Inc.(WellSense)首席执行官。2003年1月至2011年8月,他是Meditech Advisors LLC的风险投资合伙人。Machover从1989年到2010年5月担任GE Capital美国、欧洲和亚洲多个业务开发和并购职位,领导GE&8217;s以色列业务整合,被任命为General Electric Israel全国执行官,监管GE&8217;s在以色列的所有活动。Machover先生拥有Emerson College商业传播学士学位和Boston College金融和营销工商管理硕士学位。


Eitan Machover has served on our board of directors as an external director since October 2017. Mr. Machover is a partner in Meditech Advisor LLC, and he is the founder and CEO of EM Advisory Services LTD. Mr. Machover also serves as a director at VVT Medical Ltd. Epsilon Underwriting Ltd. and STG Ltd., and Electra Real Estate Ltd. He is also an observer of The Shanti House NGO board. Mr. Machover holds a B.A. in Business Communications from Emerson College, and an M.B.A from Boston College in Massachusetts.
Eitan Machover自2014年12月起担任公司董事。Machover先生自2011年8月起担任EM Advisory Services的负责人和所有者。Machover自2006年1月起担任Ziegler Meditech Equity Partners,L.P.(一家专注于医疗设备领域的基金)合伙人。他担任众多上市和私人公司董事会的基金代表,包括:Brenmiller Energy,Ltd.。TASE:BNRG,自2017年7月起;WCG Properties,Ltd.(TASE:WCG.B2),自2017年6月起;Electra Real Estate(TASE:ELCRE),自2014年10月起;Related Commercial Portfolio,Ltd.(TASE:RLCM.B1),自2015年7月起;Medigus,Ltd.(TASE:MDGS,NASDAQ:MDGS),自2016年9月起;以及Epsilon Underwriting,Ltd.,自2015年12月起。Machover从2013年1月到2014年4月担任Enhanced Surface Dynamics Inc.(WellSense)首席执行官。2003年1月至2011年8月,他是Meditech Advisors LLC的风险投资合伙人。Machover从1989年到2010年5月担任GE Capital美国、欧洲和亚洲多个业务开发和并购职位,领导GE&8217;s以色列业务整合,被任命为General Electric Israel全国执行官,监管GE&8217;s在以色列的所有活动。Machover先生拥有Emerson College商业传播学士学位和Boston College金融和营销工商管理硕士学位。
Eitan Machover has served on our board of directors as an external director since October 2017. Mr. Machover is a partner in Meditech Advisor LLC, and he is the founder and CEO of EM Advisory Services LTD. Mr. Machover also serves as a director at VVT Medical Ltd. Epsilon Underwriting Ltd. and STG Ltd., and Electra Real Estate Ltd. He is also an observer of The Shanti House NGO board. Mr. Machover holds a B.A. in Business Communications from Emerson College, and an M.B.A from Boston College in Massachusetts.
Eugene Saragnese
暂无中文简介

Eugene Saragnese joined our company as chairman of the Board and chief executive officer in January 2016. Prior to joining us, Mr. Saragnese served as chief executive officer of Phillips Imaging System, and as a member of the executive team, at Philips Healthcare from April 2009 to May 2015. Previous to that time, he held various positions at G.E. Healthcare from December 1995 through April 2009 including, most recently, Vice President and general manager of Molecular Imaging and Computer Tomography from March 2005 to April 2009 following his role as Chief Technology Officer and Vice President - Global Technology from August 2000 to March 2005 following his roles as general manager global sourcing, general manager global magnetic resonance business, general manager global magnetic resonance engineering. Prior to his time at G.E., Mr. Saragnese served in the Aerospace industry as program director of I.N.T.E.L.S.A.T at Lockheed Martin, and as manager of spacecraft groups at R.C.A. Astrospace and G.E. Astrospace prior to that time. Mr. Saragnese serves as chairman of the Board of Mirada Medical since September 2015. He holds a BS degree in Mechanical Engineering from Rutgers University.
暂无中文简介
Eugene Saragnese joined our company as chairman of the Board and chief executive officer in January 2016. Prior to joining us, Mr. Saragnese served as chief executive officer of Phillips Imaging System, and as a member of the executive team, at Philips Healthcare from April 2009 to May 2015. Previous to that time, he held various positions at G.E. Healthcare from December 1995 through April 2009 including, most recently, Vice President and general manager of Molecular Imaging and Computer Tomography from March 2005 to April 2009 following his role as Chief Technology Officer and Vice President - Global Technology from August 2000 to March 2005 following his roles as general manager global sourcing, general manager global magnetic resonance business, general manager global magnetic resonance engineering. Prior to his time at G.E., Mr. Saragnese served in the Aerospace industry as program director of I.N.T.E.L.S.A.T at Lockheed Martin, and as manager of spacecraft groups at R.C.A. Astrospace and G.E. Astrospace prior to that time. Mr. Saragnese serves as chairman of the Board of Mirada Medical since September 2015. He holds a BS degree in Mechanical Engineering from Rutgers University.
Sim Mann
暂无中文简介

Sim Mann Sim Mann has served as a director of the Company since July 2015. Mr. Mann serves as a general partner and chief strategy officer at Exigent Capital, and is responsible for that firm’s private equity, venture capital, and Israel focused investments. Prior to joining Exigent in June 2015 Sim invested over $1b in distressed debt and special situation investments in Europe and Israel on behalf of York Capital Management, a global investment firm. During his time at York from 2008-2015 Sim played a key role in three of the largest corporate debt restructurings in Israel’s history and was also intimately involved in early to late stage technology investments and multi-jurisdictional European public and private credit opportunities. Sim serves as a director on multiple portfolio companies including InSightec, ARQ, and StorePower.
暂无中文简介
Sim Mann Sim Mann has served as a director of the Company since July 2015. Mr. Mann serves as a general partner and chief strategy officer at Exigent Capital, and is responsible for that firm’s private equity, venture capital, and Israel focused investments. Prior to joining Exigent in June 2015 Sim invested over $1b in distressed debt and special situation investments in Europe and Israel on behalf of York Capital Management, a global investment firm. During his time at York from 2008-2015 Sim played a key role in three of the largest corporate debt restructurings in Israel’s history and was also intimately involved in early to late stage technology investments and multi-jurisdictional European public and private credit opportunities. Sim serves as a director on multiple portfolio companies including InSightec, ARQ, and StorePower.
Barak Avraham Salomon
暂无中文简介

Barak Avraham Salomon has served as a director of our Company since January 2018. Mr. Salomon has extensive experience in private equity investments in the technology and industrial sectors. Since 2014 Mr. Barak heads the activities of NTT DOCOMO Ventures a Japanese company related to its investments in Israel. Since 2017 Mr. Barak also serves as board member at Amir Marketing & Investments in Agriculture Ltd. (TASE: AMRK), an Israeli public company, where he is a member of the audit committee and the chairman of the compensation committee. In addition, since 2015 Mr. Barak has been a non-executive board member at Albert Technologies Ltd. (formerly Adgorithms Ltd.) (AIM: ALB.L), where he also serves on the audit committee and as chairman of the compensation committee. From 2007 to 2011 Mr. Barak was with Viola Private Equity, a technology growth capital and buyout fund, managing the investment team and executing investments in the technology and industrial sectors. Prior to Viola (from 2004 to 2006), Mr. Barak worked in the Technology group of Apax Partners in Israel. Mr. Barak holds an MBA from the MIT Sloan School of Management and a Bachelor’s degree in mathematics and computer science (cum laude) from Bar Ilan University in Israel.
暂无中文简介
Barak Avraham Salomon has served as a director of our Company since January 2018. Mr. Salomon has extensive experience in private equity investments in the technology and industrial sectors. Since 2014 Mr. Barak heads the activities of NTT DOCOMO Ventures a Japanese company related to its investments in Israel. Since 2017 Mr. Barak also serves as board member at Amir Marketing & Investments in Agriculture Ltd. (TASE: AMRK), an Israeli public company, where he is a member of the audit committee and the chairman of the compensation committee. In addition, since 2015 Mr. Barak has been a non-executive board member at Albert Technologies Ltd. (formerly Adgorithms Ltd.) (AIM: ALB.L), where he also serves on the audit committee and as chairman of the compensation committee. From 2007 to 2011 Mr. Barak was with Viola Private Equity, a technology growth capital and buyout fund, managing the investment team and executing investments in the technology and industrial sectors. Prior to Viola (from 2004 to 2006), Mr. Barak worked in the Technology group of Apax Partners in Israel. Mr. Barak holds an MBA from the MIT Sloan School of Management and a Bachelor’s degree in mathematics and computer science (cum laude) from Bar Ilan University in Israel.

高管简历

中英对照 |  中文 |  英文
Eugene Saragnese
暂无中文简介

Eugene Saragnese joined our company as chairman of the Board and chief executive officer in January 2016. Prior to joining us, Mr. Saragnese served as chief executive officer of Phillips Imaging System, and as a member of the executive team, at Philips Healthcare from April 2009 to May 2015. Previous to that time, he held various positions at G.E. Healthcare from December 1995 through April 2009 including, most recently, Vice President and general manager of Molecular Imaging and Computer Tomography from March 2005 to April 2009 following his role as Chief Technology Officer and Vice President - Global Technology from August 2000 to March 2005 following his roles as general manager global sourcing, general manager global magnetic resonance business, general manager global magnetic resonance engineering. Prior to his time at G.E., Mr. Saragnese served in the Aerospace industry as program director of I.N.T.E.L.S.A.T at Lockheed Martin, and as manager of spacecraft groups at R.C.A. Astrospace and G.E. Astrospace prior to that time. Mr. Saragnese serves as chairman of the Board of Mirada Medical since September 2015. He holds a BS degree in Mechanical Engineering from Rutgers University.
暂无中文简介
Eugene Saragnese joined our company as chairman of the Board and chief executive officer in January 2016. Prior to joining us, Mr. Saragnese served as chief executive officer of Phillips Imaging System, and as a member of the executive team, at Philips Healthcare from April 2009 to May 2015. Previous to that time, he held various positions at G.E. Healthcare from December 1995 through April 2009 including, most recently, Vice President and general manager of Molecular Imaging and Computer Tomography from March 2005 to April 2009 following his role as Chief Technology Officer and Vice President - Global Technology from August 2000 to March 2005 following his roles as general manager global sourcing, general manager global magnetic resonance business, general manager global magnetic resonance engineering. Prior to his time at G.E., Mr. Saragnese served in the Aerospace industry as program director of I.N.T.E.L.S.A.T at Lockheed Martin, and as manager of spacecraft groups at R.C.A. Astrospace and G.E. Astrospace prior to that time. Mr. Saragnese serves as chairman of the Board of Mirada Medical since September 2015. He holds a BS degree in Mechanical Engineering from Rutgers University.
Robert Jonathan Mehler
暂无中文简介

Robert Jonathan Mehler,a cofounder of our Company, has served as a director of our company since October 2013 and as our chief operating officer since January 2015. He will step down from the board of directors upon the listing of our ordinary shares on the NASDAQ Capital Market. Mr. Mehler served as vice president, business operations at GENBAND fring NASDAQ: RBBN, a global Over-the-Top (OTT) platform enabling Communications Service Providers (CSPs) to provide instant messaging, voice and video services to their subscribers, from Sept. 2012 until November 2015. Prior to that, Mr. Mehler served as Vice President, Customer Operations at ActivePath Inc. (formerly, PostalGuard Ltd.) from May 2009 until May 2012. Mr. Mehler has over 10 years of hi-tech business management experience primarily in the financial services industry. He held management positions at ObserveIT, Correlix (TSA Associates), Gotham Technology Group, and was a Venture Consultant at Genesis Partners, one of Israel’s leading Venture Capital funds, as well as a Senior Consultant at Arthur Andersen Business Consulting. Mr. Mehler holds a B.A. in Middle Eastern Studies and Languages from Columbia University.
暂无中文简介
Robert Jonathan Mehler,a cofounder of our Company, has served as a director of our company since October 2013 and as our chief operating officer since January 2015. He will step down from the board of directors upon the listing of our ordinary shares on the NASDAQ Capital Market. Mr. Mehler served as vice president, business operations at GENBAND fring NASDAQ: RBBN, a global Over-the-Top (OTT) platform enabling Communications Service Providers (CSPs) to provide instant messaging, voice and video services to their subscribers, from Sept. 2012 until November 2015. Prior to that, Mr. Mehler served as Vice President, Customer Operations at ActivePath Inc. (formerly, PostalGuard Ltd.) from May 2009 until May 2012. Mr. Mehler has over 10 years of hi-tech business management experience primarily in the financial services industry. He held management positions at ObserveIT, Correlix (TSA Associates), Gotham Technology Group, and was a Venture Consultant at Genesis Partners, one of Israel’s leading Venture Capital funds, as well as a Senior Consultant at Arthur Andersen Business Consulting. Mr. Mehler holds a B.A. in Middle Eastern Studies and Languages from Columbia University.
Michael Rosenberg
暂无中文简介

Michael Rosenberg,a cofounder of our Company, has served as a director and chief financial officer of our company since October 2013. He will step down from the board of directors upon the listing of our ordinary shares on the NASDAQ Capital Market. Prior to joining our company, he served as CFO at Pursway, Ltd. acquired by IPG Media Brands a machine learning marketing management company from June 2010 until August 2014. Prior to that time, Mr. Rosenberg served as Executive Vice President at Telecontinuity, Inc. from August 2003 through October 2009. Prior to that time, Mr. Rosenberg served as Vice President of Professional Services and Corporate Development of Elcom International from June 1994 until July 2003. Mr. Rosenberg earned a BA in Economics from Yeshiva University.
暂无中文简介
Michael Rosenberg,a cofounder of our Company, has served as a director and chief financial officer of our company since October 2013. He will step down from the board of directors upon the listing of our ordinary shares on the NASDAQ Capital Market. Prior to joining our company, he served as CFO at Pursway, Ltd. acquired by IPG Media Brands a machine learning marketing management company from June 2010 until August 2014. Prior to that time, Mr. Rosenberg served as Executive Vice President at Telecontinuity, Inc. from August 2003 through October 2009. Prior to that time, Mr. Rosenberg served as Vice President of Professional Services and Corporate Development of Elcom International from June 1994 until July 2003. Mr. Rosenberg earned a BA in Economics from Yeshiva University.
Christopher Alan Schnee
暂无中文简介

Christopher Alan Schnee has served as our senior vice president commercial operations since May 2018. Prior to that time, Mr. Schnee served as Vice President of Global Marketing and International Sales at Centurion Medical from February 2015- November 2018 and before that, as General Manager of Christie Medical Holdings from October 2007- February 2015. Mr. Schnee received a Bachelor of Science in Chemistry from the University of Texas at Austin.
暂无中文简介
Christopher Alan Schnee has served as our senior vice president commercial operations since May 2018. Prior to that time, Mr. Schnee served as Vice President of Global Marketing and International Sales at Centurion Medical from February 2015- November 2018 and before that, as General Manager of Christie Medical Holdings from October 2007- February 2015. Mr. Schnee received a Bachelor of Science in Chemistry from the University of Texas at Austin.